NCT04466969已完成不适用
Assessment of Hyperkalemia's Illness and Treatment Burden in Chronic Kidney Disease and Heart Failure Patients: HK Registry Pilot Study
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- AstraZeneca
- 入组人数
- 146
- 试验地点
- 1
- 主要终点
- Analyse descriptive statistics of PROs
研究概览
简要总结
Overall study aim of this study is to analyse descriptive statistics of Patient-Reported Outcome（PROs） which will be used in the Hyperkalemia（HK） registry study in hyperkalemia patients with Chronic Kidney Disease（CKD） or Heart Failure（HF） to describe the practice patterns of hyperkalemia treatment in in clinical practice. Based on these assessments, this study will provide the information for the applicability of PRO measurements which will be used in the Hyperkalemia registry study to the study population, i.e. CKD and/or HF patients with hyperkalemia
研究设计
- 研究类型
- Observational
- 观察模型
- Other
- 时间视角
- Prospective
入排标准
- 年龄范围
- 20 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Outpatients aged ≥20 years
- •Hyperkalemia patients defined as meeting either of the following criteria:
- •Having a history of S-K ≥5.1 mmol/L ≥2 times within 6 months before enrolment
- •Having a history of S-K ≥5.5 mmol/L once within 6 months before enrolment
- •Currently treated by potassium binders for the treatment of hyperkalemia at enrolment
- •Having been diagnosed as CKD (≥stage 3b) or HFrEF by investigators as defined below:
- •CKD is diagnosed based on the guidelines of CKD issued by the Japanese Society of Nephrology (JSN, 2018) as being either or both of condition 1 and 2 for ≥3 months
- •Clear sign of kidney impairment based on urinalysis, imaging, blood test, or biopsy. Especially, existence of ≥0.15 g/gCr of proteinuria (≥30 mg/gCr of albuminuria) is important.
- •GFR <45 mL/min/1.73m2 Within the routine clinical practice, GFR is estimated by serum creatinine, gender, and age using following the formulation.
- •eGFR creat (mL/min/1.73m2) = 194 x serum creatinine (mg/dL)-1.094 x age (years)-0.287 (for female patients, x 0.739)
- •≥Stage 3b CKD is diagnosed based on the following eGFR categories:
- •Stage 3b: 30 mL/min/1.73m2 ≤ eGFR <45 mL/min/1.73m2
- •Stage 4: 15 mL/min/1.73m2 ≤ eGFR <30 mL/min/1.73m2
- •Stage 5: eGFR <15 mL/min/1.73m2
- •Patients with HFrEF is enrolled if patients meet following criteria within 6 months:
- •NYHA class II-IV
- •Provision of signed, written, and detailed informed consent
- •Signed written informed consent by themselves
排除标准
- •Currently on any chronic RRT (including hemodialysis or peritoneal dialysis >30 days, or kidney transplant) within 6 months before enrolment
- •Patients with acute kidney injury at enrolment •Patients who took blood transfusion or potassium supplements within 6 months before enrolment
- •Active malignancy or life expectancy of less than 6 months.
- •Patients who have GI disturbance/chronic diarrhoea/stoma, and investigators determine those affect significantly serum K level
- •Patients who have autoimmune disorders, and investigators determine those affect significantly serum K level
- •Patients whose lab data have suspicion for pseudohyperkalemia
- •Patients who are pregnant, lactating, or planning to become pregnant
- •Current participation in interventional studies and/or clinical trials
- •Patients who, in the opinion of the investigators, would be unlikely to comply with self-assessments
结局指标
主要结局
Analyse descriptive statistics of PROs
时间窗: 4weeks
The primary focus of this study is to analyse descriptive statistics of PROs which will be used in the Hyperkalemia registry. Information on demographics, medical history, treatment patterns, medication compliance, and self-reported questionnaire will be collected.
次要结局
未报告次要终点
研究者
研究点 (1)
Loading locations...
相似试验
已完成
不适用
An Observational Prospective Cohort Study for Long-term Management of Hyperkalemia in Patients With Chronic Kidney Disease or Heart FailureHyperkalemiaNCT05297409AstraZeneca352
Unknown
不适用
Retrospective Survey of Hyperkalemia in HemodialysisHemodialysis ComplicationNCT05020717Peking University People's Hospital300
已完成
不适用
Tracking Treatment Pathways in Adult Patients With Hyperkalemia.HyperkalemiaNCT05408039AstraZeneca1,331
已完成
不适用
Prospective Study Measuring Clinical Outcomes of Knee Arthroplasty Using the VERASENSE™ Knee SystemOsteoarthritis, Avascular Necrosis, Rheumatoid Arthritis, Post-traumatic ArthritisNCT01469299Orthosensor, Inc.285
招募中
不适用
Patterns of Neurodevelopmental DisordersNeurodevelopmental DisordersPediatric Autoimmune Neuropsychiatric Disorder Associated With Streptococcal InfectionPediatric Acute-Onset Neuropsychiatric SyndromeDown SyndromeMitochondrial EncephalomyopathiesCerebral Folate DeficiencyEpilepsyAutism Spectrum DisorderNCT06213090Richard Frye1,000